Coronavirus vaccine rollout could benefit from ‘hyperlocal surveillance system,’ expert says
November 17 2020, 08:00
Following breaking news on Monday that Moderna’s coronavirus vaccine candidate reached 94.5% efficacy in an ongoing trial, a group of infectious disease experts addressed vaccine rollout.
Following breaking news on Monday that Moderna’s coronavirus vaccine candidate reached 94.5% efficacy in an ongoing trial, a group of infectious disease experts addressed vaccine rollout.
Source:
FOX News